Results of the 2017 global WHO survey on mycetoma – Résultats de l’enquête mondiale de l’OMS surle mycétome, 2017

World Health Organization = Organisation mondiale de la Santé.
Wkly. epidemiol. rec; 93(33): 423-428, 2018-08-17.
Artigo em Inglês, Francês | WHOLIS | ID: who-274019

Documentos relacionados

  1. Madurella mycetomatis grains within a eumycetoma lesion are clonal.
  2. Wako ß-D-glucan assay can be used to measure serum ß-D-glucan in Sudanese patients to aid with diagnosis of eumycetoma caused by Madurella mycetomatis.
  3. Using (1,3)-ß-D-glucan concentrations in serum to monitor the response of azole therapy in patients with eumycetoma caused by Madurella mycetomatis.
  4. In depth search of the Sequence Read Archive database reveals global distribution of the emerging pathogenic fungus Scedosporium aurantiacum.
  5. Complete Genome Sequence of the Itraconazole Decreased Susceptible Madurella fahalii Type-Strain CBS 129176.
  6. Diagnostics to support mycetoma management-Development of two target product profiles.
  7. Diagnostic implications of mycetoma derived from Madurella pseudomycetomatis isolates from Mexico.
  8. Inhibiting DHN- and DOPA-melanin biosynthesis pathway increased the therapeutic value of itraconazole in Madurella mycetomatis infected Galleria mellonella.
  9. A novel experimental immunomodulatory therapy against Nocardia brasiliensis in a BALB/c murine model.
  10. Dermoscopic features of actinomycetoma: a case series.